IRIS UniCatt

Pagano, Livio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.941
AS - Asia 11.216
EU - Europa 10.967
SA - Sud America 2.259
Continente sconosciuto - Info sul continente non disponibili 513
AF - Africa 303
OC - Oceania 23
Totale 41.222
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.434
SG - Singapore 5.196
DE - Germania 3.636
CN - Cina 2.739
BR - Brasile 1.822
SE - Svezia 1.524
IT - Italia 1.362
FR - Francia 924
VN - Vietnam 858
UA - Ucraina 840
IE - Irlanda 535
IN - India 500
NL - Olanda 457
GB - Regno Unito 450
ID - Indonesia 366
RU - Federazione Russa 305
FI - Finlandia 291
JP - Giappone 246
PL - Polonia 239
HK - Hong Kong 212
CA - Canada 200
BD - Bangladesh 187
TR - Turchia 183
IQ - Iraq 160
MX - Messico 151
AR - Argentina 148
ES - Italia 85
KR - Corea 80
ZA - Sudafrica 74
PK - Pakistan 73
AT - Austria 67
SA - Arabia Saudita 66
EC - Ecuador 64
CO - Colombia 55
VE - Venezuela 51
BE - Belgio 46
EG - Egitto 46
CL - Cile 40
JO - Giordania 39
KE - Kenya 36
MA - Marocco 34
UZ - Uzbekistan 33
IL - Israele 32
JM - Giamaica 28
RO - Romania 28
AE - Emirati Arabi Uniti 26
CZ - Repubblica Ceca 25
KZ - Kazakistan 25
PY - Paraguay 25
CI - Costa d'Avorio 24
CR - Costa Rica 24
LT - Lituania 23
PH - Filippine 23
PE - Perù 20
AU - Australia 19
MY - Malesia 19
AZ - Azerbaigian 17
CH - Svizzera 17
TH - Thailandia 17
IR - Iran 16
TN - Tunisia 16
BO - Bolivia 15
DZ - Algeria 15
HN - Honduras 15
UY - Uruguay 15
NP - Nepal 14
TT - Trinidad e Tobago 13
AL - Albania 11
DO - Repubblica Dominicana 11
ET - Etiopia 11
GR - Grecia 11
HU - Ungheria 11
MD - Moldavia 11
NG - Nigeria 11
PS - Palestinian Territory 11
GT - Guatemala 10
OM - Oman 10
AM - Armenia 9
BB - Barbados 9
BH - Bahrain 9
NI - Nicaragua 9
PR - Porto Rico 9
LV - Lettonia 8
PA - Panama 8
AO - Angola 7
BG - Bulgaria 7
DK - Danimarca 7
EU - Europa 7
SN - Senegal 7
HR - Croazia 6
LY - Libia 6
BY - Bielorussia 5
GE - Georgia 5
KG - Kirghizistan 5
LA - Repubblica Popolare Democratica del Laos 5
LB - Libano 5
NO - Norvegia 5
PT - Portogallo 5
QA - Qatar 5
SV - El Salvador 5
Totale 40.626
Salva come PNG Salva come JPEG
Città #
Singapore 2.617
Ashburn 1.789
Chandler 1.626
San Jose 1.554
Jacksonville 530
Dublin 525
Beijing 454
San Mateo 401
Los Angeles 394
Amsterdam 375
New York 367
Jakarta 336
Lauterbourg 317
Ann Arbor 312
Ho Chi Minh City 308
Hefei 305
Frankfurt am Main 301
Wilmington 289
Nanjing 276
Milan 263
Chicago 249
Hanoi 221
Dearborn 216
Tokyo 211
Rome 210
Boston 208
Houston 204
Munich 202
Hong Kong 196
Warsaw 192
Hyderabad 191
Nürnberg 186
Moscow 185
Woodbridge 184
Dallas 173
Lawrence 170
Buffalo 167
São Paulo 165
Bremen 158
Hangzhou 158
St Louis 150
Cattolica 129
Santa Clara 126
Zhengzhou 117
Princeton 102
Boardman 98
Seattle 96
The Dalles 94
Council Bluffs 93
Marseille 91
Nanchang 91
Redwood City 89
Kent 83
Izmir 81
Fairfield 80
Seoul 75
Shanghai 73
Atlanta 70
Nuremberg 70
Redmond 69
Rio de Janeiro 66
Paris 65
Orem 63
Mountain View 60
Phoenix 60
Shenyang 60
Tianjin 60
Baghdad 59
Hebei 57
Toronto 55
Brooklyn 54
Kunming 53
Lancaster 53
Mexico City 48
Philadelphia 48
Memphis 47
Norwalk 45
Brussels 44
Changsha 44
University Park 43
Helsinki 42
Jiaxing 42
Belo Horizonte 41
Guangzhou 41
San Francisco 41
London 40
Washington 40
Montreal 39
Da Nang 38
Amman 36
Chennai 35
Leawood 35
Cambridge 34
Denver 34
Dhaka 33
Charlotte 32
Brasília 31
Haiphong 31
Nairobi 31
Poplar 31
Totale 20.873
Salva come PNG Salva come JPEG
Nome #
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 639
Factors associated with mortality in bacteremic patients with haematologic malignancies 529
A prospective survey of febrile events in hematological malignancies 463
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 437
Incidence of acute myeloid leukemia after breast cancer 386
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 386
Factors associated with mortality in bacteremic patients with hematologic malignancies. 380
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 354
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort 341
A prospective survey of febrile events in hematological malignancies 319
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies 313
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 293
Therapy-related leukemias and myelodysplasia : susceptibility and incidence. 289
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature 284
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 240
Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin 236
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 233
Factors associated with mortality in bacteremic patients with hematologic malignancies. 220
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 215
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 215
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 202
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 199
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 198
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 198
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 195
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 194
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 188
Epigenetic changes in therapy-related MDS/AML 187
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 187
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 185
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 177
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 175
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients 175
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 174
Similarities and differences between therapy-related and elderly acute myeloid leukemia 172
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 171
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 171
Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report 171
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 169
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 168
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 167
Primary plasma cell leukemia followed by testicular plasmacytoma 166
Hyperleukocytosis and leukostasis: management of a medical emergency 165
Hyperleukocytosis and leukostasis: management of a medical emergency 164
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. 162
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 162
Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia 159
Serum beta 2 microglobulin in psoriasis and psoriatic patients 159
A prospective survey of febrile events in hematological malignancies 157
Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency 157
Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection 156
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 156
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto SCTsuccessfully treated with combination treatment. 155
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 155
Advanced mast cell disease: an Italian Hematological Multicenter experience. 154
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 153
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 153
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 153
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 152
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 151
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party 151
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) 151
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 150
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study 149
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 149
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 148
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 147
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis 146
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey 146
A patient with acute myeloid leukemia and a solid mass in the colon. 144
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 144
Outcome of therapy-related myeloid neoplasms treated with azacitidine 142
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 142
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry 141
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 141
Tunneling Schmorl?s Nodes in an Elderly Woman Treated for Acute Lymphoblastic Leukemia. 140
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report 140
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey 139
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107) 138
In vitro susceptibility of Candida species isolated from patients with haematological malignancies 138
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 137
Uncommon yeast infections in hematological patients: from diagnosis to treatment 137
SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders 137
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 136
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 136
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 135
First case of breakthrough pneumonia due to Aspergillus nomius in a patient with acute myeloid leukemia 134
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 134
Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. 133
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 133
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 133
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 133
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) 131
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients 131
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 131
High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. 130
Caspofungin for the treatment of candidaemia in patients with haematological malignancies 130
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? 127
. Pulmonary aspergillosis: lights and shadows 127
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches 127
Totale 19.122
Salva come PNG Salva come JPEG
Categoria #
all - tutte 175.950
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.950
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.938 0 151 34 88 148 76 33 331 114 156 330 477
2022/20234.593 522 559 396 770 365 584 166 373 559 94 158 47
2023/20242.506 125 738 92 81 95 348 203 51 36 91 301 345
2024/20255.979 167 165 397 189 444 149 227 265 960 650 1.358 1.008
2025/202614.898 2.181 373 866 1.465 2.354 1.275 2.355 758 989 1.130 487 665
2026/20271.974 607 1.367 0 0 0 0 0 0 0 0 0 0
Totale 41.222